Market Place
Sourcing Support
Protagonist Reveals Q3 2025 Financials & Corporate Update
06 Nov 2025 //
PHARMIWEB
Icotrokinra Shows 28-Week Efficacy, Safety in Ulcerative Colitis
27 Oct 2025 //
PR NEWSWIRE
Protagonist`s Icotrokinra Data in Ulcerative Colitis & Psoriasis
27 Oct 2025 //
PHARMIWEB
Icotrokinra Shows Durable Skin Clearance in Psoriasis Patients
24 Oct 2025 //
PR NEWSWIRE
J&J Eyes Takeover Of Immunology Partner Protagonist: WSJ
11 Oct 2025 //
FIERCE BIOTECH
Protagonist Reports Icotrokinra UC Data Showing Strong Efficacy
07 Oct 2025 //
PHARMIWEB
Icotrokinra Outperforms Deucravacitinib In Head-To-Head Trials
29 Sep 2025 //
PHARMAWEB
Protagonist Presents Icotrokinra Data for Plaque Psoriasis
17 Sep 2025 //
PHARMAWEB
Protagonist`s Icotrokinra Ph 2b Data to be Presented at UEG Week
15 Sep 2025 //
ACCESSWIRE
J&J Pursues 1st EMA Approval for Icotrokinra in Plaque Psoriasis
11 Sep 2025 //
GLOBENEWSWIRE
Protagonist Submits Icotrokinra EMA Application for Psoriasis
11 Sep 2025 //
ACCESSWIRE
Icotrokinra: 75% of adolescents with psoriasis achieve clear skin
10 Apr 2025 //
PR NEWSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.